Prestige Wealth Management Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Prestige Wealth Management Group's ELV Position: Q2 2026 in Review
Prestige Wealth Management Group reduced its Elevance Health (ELV) stake by 82% in Q2 2026, selling an estimated $154K and leaving 89 shares worth $34.5K. The position accounts for 0.01% of the portfolio, ranked #303.
Prestige Wealth Management Group first reported a position in ELV in Q4 2018 and has held it in 29 quarters since. The position peaked at $821K in Q1 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Prestige Wealth Management Group held 89 shares of Elevance Health worth $34.5K as of Q2 2026.
- Prestige Wealth Management Group sold 416 Elevance Health shares in Q2 2026, an estimated $154K.
- Elevance Health made up 0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #303 holding.
- Prestige Wealth Management Group first reported a position in Elevance Health in Q4 2018 and has held it in 29 quarters since.
- Prestige Wealth Management Group's Elevance Health position peaked at $821K in Q1 2023.
- 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.